Gieser D K, Hodapp E, Goldberg I, Kass M A, Becker B
Ann Ophthalmol. 1981 Jul;13(7):831-3.
Systemic or topical administration of corticosteroids may produce a rise in intraocular pressure (IOP). Nonsteroidal anti-inflammatory drugs (NSAI drugs) are alternate therapy for ocular inflammatory disease. Flurbiprofen, a new NSAI drug, was tested in double-masked fashion to delineate its effect on IOP. Flurbiprofen did not alter IOP in known high corticosteroid responders nor did it block corticosteroid-induced ocular hypertension.
全身或局部使用皮质类固醇可能会导致眼压升高。非甾体抗炎药（NSAI药物）是眼部炎症性疾病的替代疗法。新型NSAI药物氟比洛芬以双盲方式进行测试，以确定其对眼压的影响。氟比洛芬在已知对皮质类固醇反应强烈的患者中不会改变眼压，也不会阻止皮质类固醇诱发的高眼压。
